Drugs / SM-001
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05894902 Comparator | Oct 2023 → Apr 2024 | major depressive disorder, post-traumatic stress disorder | Advanced Integrative Medical Science Institute | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SM-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05894902 ↗ |
| Route | Oral | “single dose of SM-001 taken orally by healthy adult volunteers” NCT05894902 ↗ |